-
Our employees are the foundation upon which our business is built. Their expertise, intelligence and creativity drive our innovation, and their passion and commitment to excellence are the cornerstone of our success.
-
Our Board is currently comprised of eleven members, each of whom has a term expiring at the Company’s 2024 annual general meeting of shareholders.
-
Integrity is a core Alkermes value and the foundation of the way we do business. Alkermes is dedicated to upholding legal, regulatory and ethical standards in the markets in which we operate and to maintaining a strong culture of compliance.
-
Employee engagement remained a top priority for the Company throughout 2022. As many of our office-based employees have adapted to a hybrid work model, we’ve continued the innovative communications strategies developed throughout the COVID-19 pandemic to keep employees connected.
-
We have developed and now manufacture and commercialize proprietary medicines for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder - disease areas with vulnerable patient populations who are often treated in public health.
-
We understand the significant potential impacts that pharmaceuticals can have on the environment.
-
We strive to conduct our business activities in a manner that minimizes the environmental impacts of our operations and promotes effective stewardship of environmental resources.
-
This month we recognize Movember, a time for us to shine a light on issues affecting men’s health. Excessive drinking may affect men’s mental, sexual and physical health.
-
All Alkermes facilities have comprehensive waste management plans in place. We strive to reduce our generation of waste at each source and assess opportunities for circularity - a production and consumption model which involves reusing, repairing, refurbishing and recycling.
-
This month, Alkermes acknowledges the important role of family members who are caregivers for their loved ones.
-
Alkermes is committed to safe and sustainable research, development, manufacturing and commercialization of medicines. We implement this commitment by integrating EHSS risk management requirements throughout the lifecycle of each of our products.
-
Today and every day, we give thanks to all those providing care to loved ones. We recognize that caregiving can have an immense toll on one’s overall well-being.
-
Alkermes is committed to operating in a manner that protects our employees, our environment and our communities.
-
We recognize that our stakeholders – including employees, healthcare providers, patients, caregivers, investors, policy makers, members of the communities where we live and work, and others – are part of a single global community and affect one another.
-
Alkermes’ mission is to research, develop and commercialize important new medicines for patients suffering from complex medical conditions, including those who are often unfairly marginalized or stigmatized because of their illness.
-
On Team Alkermes, we believe that diverse voices and perspectives bring immeasurable value to our organization and the patients we serve.
-
Mental Health conditions among adults are on the rise across the country, which makes mental health screening more important than ever.
-
Corporate responsibility is foundational to our business. We are proud to release our latest Corporate Responsibility Report, which details our progress in 2022 related to environmental sustainability, diversity, inclusion and belonging and ethical governance.
-
September is Ovarian Cancer Awareness Month. We stand in solidarity with patients, caregivers and family members whose lives have been impacted by Ovarian Cancer.
-
The Alkermes Pathways Research Awards are open for applications! This program is open to all early-career investigators studying bipolar disorder or schizophrenia.
-
On World Suicide Prevention Day, we remember all those affected by suicide. In 2020, the United States had 1 death by suicide every 11 minutes. But help is available.
-
Alkermes plc (Nasdaq: ALKS) announced that it will begin accepting applications for its annual Alkermes Pathways Research Awards® program on Friday, Sept. 15, 2023.
-
Alkermes plc (Nasdaq: ALKS) today announced the recipients of the 2023 Alkermes Inspiration Grants® program. Grants were awarded to 11 nonprofit organizations working to address the needs of people living with addiction, serious mental illness or cancer.
-
Equality for women matters every day, and at Alkermes we’re proud to empower our female colleagues across the organization.
-
On many college campuses, back to school can also mean an increase in alcohol consumption. If you have a loved one heading back to school, it’s important to speak to them about the dangers of alcohol abuse.
-
Alkermes is honored to be selected for the Bell Seal for Workplace Mental Health at Platinum for the second consecutive year.
-
Each June, Pride celebrations around the world recognize the history, contributions and importance of the LGBTQ+ community while creating space to advocate for a future defined by complete equality and inclusion.
-
This year, we’re celebrating 15 years of “Alkermes in Action,” our employee-led volunteer program that supports local non-profit organizations through hands-on activities.
-
A one-size-fits-all approach to mental health care does not work for everyone in the LGBTQ+ community.
-
This #PrideMonth, Alkermes honors the resiliency of the LGBTQ+ community.
-
On Monday we commemorate Juneteenth – also known as Freedom Day – the anniversary of the freeing of the last enslaved Black Americans, which took place on June 19th, 1865, more than two years after President Lincoln issued the Emancipation Proclamation.
-
This Men's Health Week we're shining a light on some of the unique health risks that may affect men who consume alcohol excessively and reiterating our commitment to advancing care.
-
Earlier this month, members of Alkermes’ MOSAIC employee resource group and senior Human Resources leaders participated in the 17th annual ALPFA Boston's Latina Summit.
-
In 2021, the Alkermes Inspiration Grants program funded nonprofit programs providing support for patient communities in the areas of addiction, serious mental illness and cancer. Watch this video to hear grantees’ perspectives about the impact of AIG.
-
Alkermes is proud to be selected as a 2023 Top 100 Companies Leading in Wellbeing by Ibec! This recognition acknowledges companies in Ireland who are leading the way in supporting employee wellbeing.
-
Alkermes’ Athlone site was recently shortlisted for gradireland’s 17th annual Graduate Recruitment Awards! This award recognizes outstanding graduate intake programs across Ireland.
-
Alkermes Athlone site recently received a 2023 award in the Life Sciences category at Ireland’s 2023 Health & Safety Excellence Awards.
-
The 2023 Alkermes Inspiration Grants® program is now open for applications!
-
Patients diagnosed with platinum-resistant Ovarian Cancer (PROC) often face poor prognosis due to the limited treatment options.
-
Katie Joyce, our VP of Corporate Affairs is participated in a panel discussion at this year’s Women In Bio - Engage. Educate. Empower.
-
Alkermes plc (Nasdaq: ALKS) recently announced that the company will accept applications for its Alkermes Inspiration Grants® program beginning on May 1, 2023.
-
Alcohol Use Disorder (AUD) does not discriminate. But some communities are disproportionately affected.
-
Alkermes Athlone Receives Award at Ireland’s 2023 Health Safety Excellence Awards Tue, 05/02/2023 - 13:20 Type of Content Multimedia with summary Layout Standard Format Body Alkermes Athlone site recently received a 2023 award in the Life Sciences category at Ireland’s 2023 Health Safety Excellence Awards. This recognition is a testament to our employees’ focus on building a culture of safety and risk management in Athlone. Learn more about this honor: https://lnkd.in/eHzGMjC About Alkermes Alke
-
As part of last month’s observance of Equal Pay Day, Alkermes reaffirms our commitment to closing long-standing pay gaps between men and women.
-
Alkermes was recently named to Ragan Communications and PR Daily’ list of Top Places to Work for 2023!
-
Last month, Alkermes’ Mosaic employee resource group hosted a conversation with Dr. Kevin M. Simon, a double-board certified psychiatrist who specializes in mental health and addiction.
-
It’s no surprise that a rising number of employees are reporting burnout from the demands of work and home, especially as a rapidly aging population requires increased levels of care.
-
Alkermes’ culture is built on our commitment to deep compassion, great science and real impact.
-
Alkermes celebrates the legacy of Dr. King and countless other Black trailblazers who have persisted in the face of injustice.
-
Alkermes is committed to improving the communities where we live and work.